Longitudinal Analysis of Objective and Self-Reported Cognitive Functions in Individuals with Subjective Cognitive Decline
Authors:
- Seon Young RyuSRSeon Young Ryu
- Chunghwee LeeCLChunghwee Lee
- SeongHee HoSHSeongHee Ho
- Yun Jeong HongYHYun Jeong Hong
- Jee Hyang JeongJJJee Hyang Jeong
- Kee Hyung ParkKPKee Hyung Park
- Min Jeong WangMWMin Jeong Wang
- Seong Hye ChoiSCSeong Hye Choi
- SangYun KimSKSangYun Kim
- Dong Won YangDYDong Won Yang
- 6 February 2025
- journal article
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 54 (4) , 246-254
Abstract
Introduction: Subjective cognitive decline (SCD) is considered a preclinical manifestation of Alzheimer’s disease (AD). Recent research suggests that subtle cognitive changes in SCD are linked to an increased risk of clinical decline. This study investigates the longitudinal trajectories of both objective and self-reported cognitive functions in individuals with SCD, with a focus on the impact of subtle cognitive impairment (SCI). Methods: A total of 107 individuals with SCD, with at least two annual follow-ups, were included in this study. We analyzed the trajectories of both objective and subjective cognitive functions, assessed changes in medial temporal lobe regional volumes, and compared baseline AD biomarkers between SCD individuals with SCI (n = 22, SCI group) and without SCI (n = 85). Results: SCD individuals with SCI showed a faster decline in objective cognitive function over time compared to those without SCI, who exhibited cognitive improvement. Self-reported cognitive complaints showed no differences between groups at baseline or in annual changes over time. The SCI group had lower baseline entorhinal cortical volumes and greater volume reductions over time and also exhibited more abnormalities in AD biomarkers, including higher amyloid PET positivity, a lower Aβ 42/40 ratio, and elevated p-tau181. Conclusion: SCI status in SCD individuals is associated with significant cognitive decline, along with more abnormal AD biomarkers. These findings suggest that early identification of SCI status in individuals with SCD may improve the prediction of cognitive decline. However, self-reported cognitive complaints may have a limited role in monitoring clinical changes in SCD.Keywords
This publication has 33 references indexed in Scilit:
- Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centersAlzheimer's & Dementia, 2022
- Elevated plasma neurofilament light predicts a faster rate of cognitive decline over 5 years in participants with objectively‐defined subtle cognitive decline and MCIAlzheimer's & Dementia, 2021
- Subtle cognitive impairment as a marker of Alzheimer's pathologies and clinical progression in cognitively normal individualsAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021
- Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementiaAlzheimer's & Dementia, 2018
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 studyAlzheimer's & Dementia, 2015
- A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's diseaseAlzheimer's & Dementia, 2014
- A New Classification System for Ischemia Using a Combination of Deep and Periventricular White Matter HyperintensitiesJournal of Stroke and Cerebrovascular Diseases, 2014
- An investigation of PreMCI: Subtypes and longitudinal outcomesAlzheimer's & Dementia, 2012
- Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991